Benzinga's Top Initiations

Analysts at Guggenheim Securities initiated coverage on

with a Buy rating. The target price for Five Prime Therapeutics is set to $31. Five Prime Therapeutics' shares closed at $21.01 yesterday. Analysts at Guggenheim Securities initiated coverage on

with a Buy rating. The target price for Merrimack Pharmaceuticals is set to $15. Merrimack Pharmaceuticals' shares closed at $11.52 yesterday. Analysts at Pacific Crest initiated coverage on

with a Sector Weight rating. Mobileye shares closed at $46.23 yesterday. Evercore Partners initiated coverage on

with a Hold rating. The target price for Criteo is set to $45. Criteo shares closed at $44.89 yesterday. Analysts at Oppenheimer initiated coverage on

with a Outperform rating. The target price for Horizon Technology is set to $15. Horizon Technology shares closed at $14.16 yesterday. Gabelli initiated coverage on

with a Hold rating. A O Smith shares closed at $68.22 yesterday. Analysts at Canaccord Genuity initiated coverage on

with a Hold rating. The target price for Royal Gold is set to $72.50. Royal Gold shares closed at $66.19 yesterday. Stifel Nicolaus initiated coverage on

with a Buy rating. The target price for US Concrete is set to $45. US Concrete shares closed at $37.60 yesterday. Analysts at Oppenheimer initiated coverage on

with a Outperform rating. The target price for Monroe Capital is set to $15. Monroe Capital shares closed at $14.62 yesterday. Canaccord Genuity initiated coverage on

with a Buy rating. Silver Wheaton shares closed at $20.14 yesterday.